Lynnea Olivarez is a savvy life science communicator with experience spanning industry, agency and government. In 2023, she founded the biopharma communicator community Ticket to Biotech (T2B) after more than a decade driving impactful communications across the drug development lifecycle. Lynnea previously managed corporate communications as a VP at gene therapy company Encoded Therapeutics. Before that, she was recognized in PR News’ Annual Top Women in PR Awards in 2020 for her work at genomic medicine leader Intellia Therapeutics. Lynnea also guided strategic communications for dozens of biopharma clients at PR firms Ten Bridge Communications and MacDougall Advisors. Earlier in her career, she led mar-comm for the Massachusetts Life Sciences Center and global IT communications at Novartis Biomedical Research. A magna cum laude Northeastern University graduate, Lynnea is 2024 president of the Public Relations Society of America SF Bay Area Chapter, and serves on the American Society of Gene and Cell Therapy Communications Committee.